CardioGenics Holdings (CardioGenics Holdings) EV-to-EBIT : 0.00 (As of Jun. 07, 2024)

CardioGenics Holdings EV-to-EBIT Chart

CardioGenics Holdings Annual Data
	Trend	Jul06	Jul07	Jul08	Oct09	Oct10	Oct11	Oct12	Oct13	Oct14	Oct15
EV-to-EBIT		Get a 7-Day Free Trial					-2.48	-6.56	-2.48	-4.71	-4.80

CardioGenics Holdings Quarterly Data
	Apr11	Jul11	Oct11	Jan12	Apr12	Jul12	Oct12	Jan13	Apr13	Jul13	Oct13	Jan14	Apr14	Jul14	Oct14	Jan15	Apr15	Jul15	Oct15	Jan16
EV-to-EBIT	Get a 7-Day Free Trial															-2.55	-1.63	-4.07	-4.80	-4.12

Competitive Comparison of CardioGenics Holdings's EV-to-EBIT

For the Diagnostics & Research subindustry, CardioGenics Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CardioGenics Holdings's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, CardioGenics Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where CardioGenics Holdings's EV-to-EBIT falls into.

CardioGenics Holdings EV-to-EBIT Calculation

CardioGenics Holdings's EV-to-EBIT for today is calculated as:

CardioGenics Holdings's current Enterprise Value is $0.00 Mil.
CardioGenics Holdings's EBIT for the trailing twelve months (TTM) ended in Jan. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.77 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CardioGenics Holdings  (OTCPK:CGNH) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

CardioGenics Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jan. 2016 is calculated as:

CardioGenics Holdings's Enterprise Value for the quarter that ended in Jan. 2016 was $3.16 Mil.
CardioGenics Holdings's EBIT for the trailing twelve months (TTM) ended in Jan. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.77 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CardioGenics Holdings EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of CardioGenics Holdings's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

CardioGenics Holdings (CardioGenics Holdings) Business Description